Dabur India Limited · NSE:DABUR
Dabur India — Q2 FY21 Earnings Presentation
31 slides from Dabur India's earnings presentation, Nov 3, 2020
Slide 1: Investors Communication cover letter to exchanges
^J^AA^. <^g& ^^f ^^-^ 0^ Ref:SEC/SE/2020-21 Date: November 03, 2020 wr India Ltd. Scrip Symbol: NSE- DABUR, BSE Scrip Code: 500096 To, Corporate Relation Department National Stock Exchange of India Ltd BSE Ltd Exchange Plaza, 5th Floor Phiroze Jeejeebhoy Towers Plot No. C/l, G Block Bandra - Kurla C
Slide 2: Q2 FY21 – Results Presentation
Q2 FY21 – Results Presentation 3rd November 2020
Slide 3: Agenda
Agenda 1 2 3 4 Macro Q2 FY21 – Business Interim Overview Performance Highlights Dividend Summary 2
Slide 4: GDP declined by 24% in Q1, FY outlook remains bleak
GDP declined by 24% in Q1, FY outlook remains bleak with projected decline of 10%+ India Real GDP Contracted By 23.9% In Q1FY21 and is expected to contract 11-13% in Q2 FY21 Real GDP Growth % 7.1% 6.2% 5.6% 5.7% 5.2% 4.4% 4.1% 3.1% Q1 FY19 Q2 FY19 Q3 FY19 Q4 FY19 Q1 FY20 Q2 FY20 Q3 FY20 Q4 FY20 Q1 F
Slide 5: Key Macro Indicators
Key Macro Indicators Month on Month improvement in Industrial Production Unemployment rate back at pre-Covid levels IIP Unemployment Rate 2.1% 2.1% 4.6% 23.5% 0.5% 21.7% (10.4%) (8.4%) 10.2% (16.6%) (15.7%) 8.8% 7.2% 7.8% 7.4% 8.4% 6.7% (34.0%) (57.6%) Jan-20 Feb-20 Mar-20 Apr-20 May-20 Jun-20 Jul-2
Slide 6: Rural continues to fare much better than urban
Rural continues to fare much better than urban Key Indicators of Rural Revival Tractor Sales have picked up pace since the Lower Unemployment Rate Kharif Crops Sowing* Scaling New Highs initial shock seen in Mar and Apr’20 Unemployment Rate for Sep’20 Tractor Sales (including Exports) – in Area unde
Slide 7: Agenda
Agenda 1 2 3 4 Macro Q2 FY21 – Business Interim Overview Performance Highlights Dividend Summary 6
Slide 8: Q2 FY21 – Performance Summary
Q2 FY21 – Performance Summary Consolidated Revenue Growth 13.7% 16.8% India FMCG Growth 19.8% India FMCG Volume International Business Growth 5.5% Growth Operating Profit Growth 16.3% Consolidated PAT Growth 19.5% 7
Slide 9: Q2 FY21 – Financials
Q2 FY21 – Financials Revenue +13.7% 2,516 • India FMCG business recorded a growth of 19.8% on the back of volume growth of 16.8% 2,212 • International Business reported 5.5% growth in INR terms (CC growth of 3.5%) Q2 FY20 Q2 FY21 Operating Profit • Consolidated Operating Margin saw a growth of 16.3%
Slide 10: Domestic FMCG Growth – By Verticals – Q2 FY21
Domestic FMCG Growth – By Verticals – Q2 FY21 Q2 FY20 Sales Contribution Q2 FY21 Sales Contribution Foods Foods 15.9% Healthcare 12.7% 31.8% Healthcare 39.6% HPC HPC 52.3% 47.6% Healthcare Home & Personal Care (HPC) Foods Growth: 49.3% Growth: 9.1% Growth: (3.8%) Ex-Enterprise, growth of 8.5% 714 85
Slide 11: Agenda
Agenda 1 2 3 4 Macro Q2 FY21 – Business Interim Overview Performance Highlights Dividend Summary 10
Slide 12: Healthcare – Q2 FY21
Healthcare – Q2 FY21 Health Supplements Digestives OTC Ethicals Growth % 70.8% 2.5% 56.1% 26.4% • Recorded strong growth on • Pudin Hara portfolio saw • Driven by strong growth in • Ethicals grew in double digits the back of ~2x sales of strong double-digit growth in Lal Tail and Shilajit Portfolio
Slide 13: New Product Launches – Healthcare
New Product Launches – Healthcare Dabur Vedic Suraksha Tea Dabur Single Herbs Range Dabur Himalayan Apple Cider Dabur Honey Tulsi Dabur Honey Ashwagandha Dabur Ayurvedic Nasal Drops Vinegar 12
Slide 14: Home and Personal Care – Q2 FY21
Home and Personal Care – Q2 FY21 Oral Care Hair Oils Shampoo Home Care Skin & Salon Growth % 24.2% (6.3%) 17.8% (10.2%) 38.1% • Red Toothpaste • Low CSD sales impacted • Shampoos portfolio • Air freshener category • Dabur Sanitize range continues to see good the business. Excluding registered strong
Slide 15: New Product Launches – HPC
New Product Launches – HPC Dabur Dant Rakshak Dabur Herb’l Clove Dabur Baby Care Range Dabur Amla Aloe Vera Hair Oil Dabur Badam Amla Hair Oil 14
Slide 16: Foods – Q2 FY21
Foods – Q2 FY21 Beverages Culinary Growth % (4.8%) 12.1% • Domestic Juices business excluding Enterprise (HORECA, FS and • Hommade brand performed well driven by increased cooking at home CSD) saw a growth of 6% • Excluding the HORECA business, Culinary business recorded • Market share of Real incre
Slide 17: New Product Launches – Foods
New Product Launches – Foods Real Low Cal Juices Real Apple Mini Dabur Cold Pressed Mustard Oil Dabur Hommade Chutney Range Dabur Hommade Imli Sauce Dabur Hommade Pickles Range 16
Slide 18: New Communication and Restyling Brands
New Communication and Restyling Brands New Communications Contextual, Competitive Restyling Brands on Innovations and Regional TVCs Healthcare Contextual HPC Competitive Foods Regional 17
Slide 19: Consumer Connect through Activations
Consumer Connect through Activations No of activities Consumer Reach With increased mobility in Q2, a big push to reach out to consumers, especially in Health care 36 3.2 Cr Stresscom Ratnaprash Ayush Kwath Kadha CRPF Health Camp Immunity @ Door step Key Activations – CTRL+ALT+DEL your stress Immuni
Slide 20: International Business – Q2 FY21 Performance
International Business – Q2 FY21 Performance Q2 FY20 Sales Contribution • International Business reported a growth of 5.5% (CC growth of 3.5%) Others 3.2% • MENA continues to be impacted by Covid and macroeconomic headwinds International • Egypt recorded a decline of 3.3% 28.2% • Hobby had a strong
Slide 21: Product Launches – Q2 FY21
Product Launches – Q2 FY21 Honitus Hot Sip Dazzl Shield – Floor and Surface Cleaners Vatika Skin Sanitizing Lotion (in UAE) (in GCC and Nigeria) (in GCC) Dabur Fruit & Veggie Clean Vatika Styling Hair Cream Vatika Afro Natural Hair Gel (in GCC) (in Egypt) (in SSA) 20
Slide 22: Product Launches – Q2 FY21
Product Launches – Q2 FY21 Hobby Kivir Kivir – Curl Defining Hair Gel Hobby – Anti Bacterial Range of Hand Gel and Body Wash (in Turkey) (Turkey) Hobby Kids Hair Gel (in Turkey) 21
Slide 23: Agenda
Agenda 1 2 3 4 Macro Q2 FY21 – Business Interim Overview Performance Highlights Dividend Summary 22
Slide 24: Interim Dividend
Interim Dividend H1 FY21 Dividend per share (INR) 1.75 Dividend % 175% Total dividend (INR cr) 309.30 23
Slide 25: Annexure
Annexure
Slide 26: Consolidated Profit and Loss Statement
Consolidated Profit and Loss Statement All figures are in INR cr Q2 FY21 Q2 FY20 Y-o-Y (%) H1 FY21 H1 FY20 Y-o-Y (%) Revenue from operations 2,516.0 2,212.0 13.7% 4,496.0 4,485.3 0.2% Other Income 87.6 81.8 7.1% 159.4 155.1 2.8% Total Income 2,603.6 2,293.8 13.5% 4,655.4 4,640.3 0.3% Material Cost 1
Slide 27: Standalone Profit and Loss Statement
Standalone Profit and Loss Statement Q2 FY21 Q2 FY20 Y-o-Y (%) H1 FY21 H1 FY20 Y-o-Y (%) Revenue from operations 1,900.9 1,612.2 17.9% 3,391.8 3,240.5 4.7% Other Income 73.2 75.1 (2.5%) 138.1 142.6 (54.5%) Total Income 1,974.1 1,687.3 17.0% 3,529.8 3,383.1 4.3% Material Cost 950.0 822.0 15.6% 1,710.
Slide 28: Consolidated Balance Sheet
Consolidated Balance Sheet All figures are in INR crores, unless otherwise stated All figures are in INR crores, unless otherwise stated As at As at As at As at Particulars 30/09/2020 31/03/2020 Particulars 30/09/2020 31/03/2020 (Unaudited) (Audited) (Unaudited) (Audited) A Assets B Equity and Liabi
Slide 29: Standalone Balance Sheet
Standalone Balance Sheet All figures are in INR crores, unless otherwise stated All figures are in INR crores, unless otherwise stated As at As at As at As at Particulars 30/09/2020 31/03/2020 Particulars 30/09/2020 31/03/2020 (Unaudited) (Audited) (Unaudited) (Audited) A Assets B Equity and Liabili
Slide 30: Breakdown of Revenue from Operations
Breakdown of Revenue from Operations All figures are in INR crores, unless otherwise stated Q2 FY21 Q2 FY20 Y-o-Y (%) H1 FY21 H1 FY20 Y-o-Y (%) Health Supplements 434 254 70.8% 743 456 62.7% Digestives 91 89 2.5% 176 185 (4.7%) OTC & Ethicals 188 134 39.8% 321 249 29.2% Healthcare 714 478 49.3% 1,24
Slide 31: For more information and updates, visit
For more information and updates, visit: http://www.dabur.com/in/en-us/investor